{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:36:47Z","timestamp":1789501007165,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejpb.2024.114524","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T02:48:37Z","timestamp":1728096517000},"page":"114524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Development of puerarin-loaded poly(lactic acid) microspheres for sustained ocular delivery: In vitro\/vivo evaluation"],"prefix":"10.1016","volume":"204","author":[{"given":"Yanqiu","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangying","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6639-6759","authenticated-orcid":false,"given":"Ning","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejpb.2024.114524_b0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S2213-8587(18)30128-1","article-title":"Incidence and progression of diabetic retinopathy: a systematic review","volume":"7","author":"Sabanayagam","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ejpb.2024.114524_b0010","first-page":"84","article-title":"Novelties in Diabetic Retinopathy","author":"Ebneter","year":"2016","journal-title":"Novelties in Diabetes"},{"issue":"11","key":"10.1016\/j.ejpb.2024.114524_b0015","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114524_b0020","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global Prevalence and Major Risk Factors of Diabetic Retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejpb.2024.114524_b0025","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.ijbiomac.2018.10.072","article-title":"Polysaccharides from Chinese herbal medicine for anti-diabetes recent advances","volume":"121","author":"Zheng","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2024.114524_b0030","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-15-8791-7","article-title":"Structure and Health Effects of Natural Products on Diabetes Mellitus","author":"Chen","year":"2021","journal-title":"Structure and Health Effects of Natural Products on Diabetes Mellitus"},{"key":"10.1016\/j.ejpb.2024.114524_b0035","article-title":"Astragaloside II Ameliorated Podocyte Injury and Mitochondrial Dysfunction in Streptozotocin-Induced Diabetic Rats","volume":"12","author":"Su","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114524_b0040","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0161-6420(02)01074-6","article-title":"The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study","volume":"109","author":"Klein","year":"2002","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ejpb.2024.114524_b0045","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019102","article-title":"Traditional chinese medicine for diabetic retinopathy","volume":"99","author":"Pang","year":"2020","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.ejpb.2024.114524_b0050","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1089\/jicm.2021.0392","article-title":"Traditional Chinese Medicine Injections for Diabetic Retinopathy: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials","volume":"28","author":"Sun","year":"2022","journal-title":"J. Integrative and Complementary Med."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114524_b0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF02934613","article-title":"Observation on Efficacy of Puerarin in Treating Diabetic Retino pathy","volume":"8","author":"Ren","year":"2002","journal-title":"Chin. J. Integrated Traditional and Western Med."},{"issue":"11","key":"10.1016\/j.ejpb.2024.114524_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11112121","article-title":"Pharmacological Activity, Pharmacokinetics, and Clinical Research Progress of Puerarin","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxidants"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2024.114524_b0065","first-page":"133","article-title":"Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats","volume":"466","author":"Li","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114524_b0070","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1080\/03639045.2018.1449856","article-title":"A microemulsion of puerarin\u2013phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations","volume":"44","author":"Wu","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"19","key":"10.1016\/j.ejpb.2024.114524_b0075","first-page":"4134","article-title":"Pharmaceutics research advances in oral administration of puerarin","volume":"44","author":"Wu","year":"2019","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.ejpb.2024.114524_b0080","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.2147\/DDDT.S374061","article-title":"Development and Evaluation of Puerarin Loaded-Albumin Nanoparticles Thermoresponsive in situ Gel for Ophthalmic Delivery","volume":"Volume 16","author":"Hu","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114524_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030216","article-title":"Preparation of Puerarin Chitosan Oral Nanoparticles by Ionic Gelation Method and Its Related Kinetics","volume":"12","author":"Yan","year":"2020","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.ejpb.2024.114524_b0090","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2174\/1389200216666151001120831","article-title":"Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection","volume":"16","author":"Semeraro","year":"2015","journal-title":"Curr. Drug Metab."},{"issue":"3","key":"10.1016\/j.ejpb.2024.114524_b0095","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular Drug Delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2024.114524_b0100","series-title":"Drug Product Development for the Back of the Eye","article-title":"Drug Product Development for the Back of the Eye","author":"Aukunuru","year":"2011"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114524_b0105","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s13346-020-00843-z","article-title":"Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives","volume":"11","author":"Gaballa","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2024.114524_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114870","article-title":"Recent advances and future prospects: Current status and challenges of the intraocular injection of drugs for vitreoretinal diseases","volume":"198","author":"Hashida","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.ejpb.2024.114524_b0115","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3109\/02652040309178090","article-title":"Poly (D, L-lactide-co-glycolide) microspheres for long-term intravitreal delivery of aciclovir: influence of fatty and non-fatty additives","volume":"20","author":"Mart\u00ednez-Sancho","year":"2003","journal-title":"J. Microencapsul."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114524_b0120","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1080\/10717544.2019.1682719","article-title":"Uniform-sized insulin-loaded PLGA microspheres for improved early-stage peri-implant bone regeneration","volume":"26","author":"Wang","year":"2019","journal-title":"Drug Deliv."},{"issue":"7","key":"10.1016\/j.ejpb.2024.114524_b0125","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2174\/1567201815666180226121020","article-title":"Biodegradable Microspheres as Intravitreal Delivery Systems for Prolonged Drug Release. What is their Eminence in the Nanoparticle Era?.","volume":"15","author":"Gavini","year":"2018","journal-title":"Current Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114524_b0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2016.02.041","article-title":"Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma","volume":"228","author":"Chiang","year":"2016","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.ejpb.2024.114524_b0135","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.3390\/ijms15046241","article-title":"Preparation of Lung-Targeting, Emodin-Loaded Polylactic Acid Microspheres and Their Properties","volume":"15","author":"Chen","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114524_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13050742","article-title":"The Preparation of a Novel Poly(Lactic Acid)-Based Sustained H2S Releasing Microsphere for Rheumatoid Arthritis Alleviation","volume":"13","author":"Yu","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114524_b0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1248\/cpb.54.89","article-title":"In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d, l-lactide acid) and poly(d, l-lactide-co-glycolide acid)","volume":"54","author":"Gao","year":"2006","journal-title":"Chem. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.ejpb.2024.114524_b0150","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-023-02691-9","article-title":"Enhancing Anticancer Efficacy of Formononetin Microspheres via Microfluidic Fabrication","volume":"24","author":"Cao","year":"2023","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.ejpb.2024.114524_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17869-y","article-title":"TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model","volume":"7","author":"Ratay","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114524_b0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/03601234.2023.2172285","article-title":"Preparation and evaluation of attractive microspheres for control of Agrilus planipennis fairmaire","volume":"58","author":"Li","year":"2023","journal-title":"J. Environ. Sci. Health B"},{"issue":"50","key":"10.1016\/j.ejpb.2024.114524_b0165","doi-asserted-by":"crossref","first-page":"12219","DOI":"10.1021\/jf403722q","article-title":"Preparation and Physicochemical Characteristics of Polylactide Microspheres of Emamectin Benzoate by Modified Solvent Evaporation\/Extraction Method","volume":"61","author":"Zhang","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejpb.2024.114524_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108823","article-title":"The sustained and targeted treatment of hemangiomas by propranolol-loaded CD133 aptamers conjugated liposomes-in-microspheres","volume":"114","author":"Guo","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejpb.2024.114524_b0175","article-title":"Studies on Interferon-alpha PLGA microspheres","author":"Song","year":"2007","journal-title":"Guangdong Pharmaceutical University"},{"key":"10.1016\/j.ejpb.2024.114524_b0180","doi-asserted-by":"crossref","unstructured":"S. Yang, Study on preparation and physicochemicalproperties of gelatin microspheres loaded withsteroidal saponins from Ophiopogon japonicas, Fujian University of Technology, 2021. 10.27865\/d.cnki.gfgxy.2021.000011.","DOI":"10.1080\/10601325.2021.1920331"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114524_b0185","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/03639040802395185","article-title":"The Effect of Chitosan Molecular Weight on the Characteristics of Spray-Dried Methotrexate-Loaded Chitosan Microspheres for Nasal Administration","volume":"35","author":"Sun","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114524_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010079","article-title":"Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis","volume":"13","author":"Vishwa","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114524_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121504","article-title":"Design, optimization, and in vitro characterization of idebenone-loaded PLGA microspheres for LHON treatment","volume":"616","author":"Varela-Fern\u00e1ndez","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114524_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106617","article-title":"Preparation, properties and in vitro osteogensis of self-reinforcing injectable hydrogel","volume":"192","author":"Wu","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114524_b0205","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ijbiomac.2022.07.195","article-title":"Preparation and in vitro release of mPEG-PLA microspheres of Panax notoginseng saponins","volume":"217","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2024.114524_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213559","article-title":"Preparation of a modified silk-based gel\/microsphere composite as a potential hepatic arterial embolization agent","volume":"153","author":"Chen","year":"2023","journal-title":"Biomater. Adv."},{"issue":"4","key":"10.1016\/j.ejpb.2024.114524_b0215","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/1567201816666181227105930","article-title":"Development and Characterization of Olanzapine Loaded Poly(lactide-co-glycolide) Microspheres for Depot Injection: In vitro and In vivo Release Profiles","volume":"16","author":"Pervaiz","year":"2019","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114524_b0220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2019.01.012","article-title":"Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma","volume":"297","author":"Arranz-Romera","year":"2019","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114524_b0225","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10792-013-9829-0","article-title":"Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis","volume":"34","author":"Li","year":"2013","journal-title":"Int. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114524_b0230","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.exer.2009.03.012","article-title":"Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone","volume":"89","author":"Barcia","year":"2009","journal-title":"Exp. Eye Res."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2024.114524_b0235","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijpharm.2006.07.010","article-title":"Vitamin A palmitate and aciclovir biodegradable microspheres for intraocular sustained release","volume":"326","author":"Mart\u00ednez-Sancho","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114524_b0240","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3109\/03639045.2015.1075032","article-title":"Development of low density azithromycin-loaded polycaprolactone microparticles for pulmonary delivery","volume":"42","author":"Kasten","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2024.114524_b0245","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejpb.2016.11.008","article-title":"Mechanistic analysis of triamcinolone acetonide release from PLGA microspheres as a function of varying in vitro release conditions","volume":"113","author":"Doty","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114524_b0250","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijpharm.2016.08.032","article-title":"Towards a better understanding of the different release phases from PLGA microparticles: Dexamethasone-loaded systems","volume":"514","author":"Gasmi","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.ejpb.2024.114524_b0255","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2174\/1567201820666221122124510","article-title":"Preparation, Characterization and in vitro\/vivo Evaluation of Long-Acting Rivaroxaban-Loaded Microspheres","volume":"20","author":"Tan","year":"2023","journal-title":"Curr. Drug Deliv."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114524_b0260","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent Perspectives in Ocular Drug Delivery","volume":"26","author":"Gaudana","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2024.114524_b0265","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ijbiomac.2016.06.076","article-title":"Preparation and drug release properties of norisoboldine-loaded chitosan microspheres","volume":"91","author":"He","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114524_b0270","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1080\/10717544.2021.1943056","article-title":"Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review","volume":"28","author":"Hua","year":"2021","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.ejpb.2024.114524_b0275","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijpharm.2008.04.042","article-title":"Principles of encapsulating hydrophobic drugs in PLA\/PLGA microparticles","volume":"364","author":"Wischke","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2024.114524_b0280","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1080\/10717544.2022.2072413","article-title":"PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation in vitro and in vivo","volume":"29","author":"Su","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114524_b0285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2023.02.024","article-title":"Preparation and evaluation of injectable microsphere formulation for longer sustained release of donepezil","volume":"356","author":"Ji","year":"2023","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ejpb.2024.114524_b0290","doi-asserted-by":"crossref","DOI":"10.3390\/polym13030360","article-title":"Berberine-Coated Biomimetic Composite Microspheres for Simultaneously Hemostatic and Antibacterial Performance","volume":"13","author":"Zhang","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.ejpb.2024.114524_b0295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.preteyeres.2014.04.002","article-title":"The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies","volume":"42","author":"Herrero-Vanrell","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2024.114524_b0300","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000434693","article-title":"Microspheres and Nanotechnology for Drug Delivery","author":"J\u00f3hannesson","year":"2016","journal-title":"Retinal Pharmacotherapeutics."},{"issue":"14","key":"10.1016\/j.ejpb.2024.114524_b0305","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","article-title":"Topical and systemic drug delivery to the posterior segments","volume":"57","author":"Hughes","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.ejpb.2024.114524_b0310","article-title":"Cyclosporine-Loaded Microspheres for Treatment of Uveitis. In Vitro Characterization and In Vivo Pharmacokinetic Study. Investigative Opthalmology & Visual","volume":"47","author":"He","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejpb.2024.114524_b0315","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jchromb.2012.12.011","article-title":"Simultaneous determination of gastrodin and puerarin in rat plasma by HPLC and the application to their interaction on pharmacokinetics","volume":"915\u2013916","author":"Jiang","year":"2013","journal-title":"J. Chromatogr. B"},{"issue":"4","key":"10.1016\/j.ejpb.2024.114524_b0320","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.3855","article-title":"Simultaneous determination of epalrestat and puerarin in rat plasma by UHPLC\u2013MS\/MS: Application to their pharmacokinetic interaction study","volume":"31","author":"Sun","year":"2016","journal-title":"Biomed. Chromatogr."},{"issue":"5","key":"10.1016\/j.ejpb.2024.114524_b0325","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/00498254.2024.2341402","article-title":"Preparation, characterisation, pharmacokinetics and distribution of esculin microspheres administered via intravitreal injection into rabbit brain","volume":"54","author":"Wu","year":"2024","journal-title":"Xenobiotica"},{"issue":"5","key":"10.1016\/j.ejpb.2024.114524_b0330","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/jps.21987","article-title":"A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases","volume":"99","author":"Choonara","year":"2010","journal-title":"J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124003503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124003503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T19:09:09Z","timestamp":1729710549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124003503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":66,"alternative-id":["S0939641124003503"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114524","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of puerarin-loaded poly(lactic acid) microspheres for sustained ocular delivery: In vitro\/vivo evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114524"}}